• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

iBiology

Bringing the World's Best Biology to You

  • Start Here
    • Explore iBiology
    • All Playlists
    • All Speakers
    • All Talks
    • What’s new at iBiology?
  • Research Talks
    • Talks by Topic
      • Biochemistry
      • Bioengineering
      • Biophysics
      • Cell Biology
      • Development and Stem Cells
      • Ecology
      • Evolution
      • Genetics and Gene Regulation
      • Human Disease
      • Immunology
      • Microbiology
      • Neuroscience
      • Plant Biology
      • Techniques
      • Archive
    • Talks by Series
      • Bench to Bedside
      • Famous Discoveries
      • Great Unanswered Questions
      • Young Scientist Series
  • Stories
    • Background to Breakthrough
    • Interviews and Profiles
    • Science and Society
  • Courses
  • Careers
    • Professional Development Talks
    • Professional Development Courses
    • Career Exploration
    • NRMN Resources
    • Biomedical Workforce
  • Educator
  • About
    • Mission
    • iBiology Team
    • Board of Directors
    • Make a Donation
    • iBiology Funders and Partnerships
    • Contact Us
Home » Speakers » Ana Ruiz Saenz
Ana Ruiz Saenz

Ana Ruiz Saenz

University of California, San Francisco

Share

Ana Ruiz-Saenz is originally from Spain and studied Biochemistry at the University Autonoma of Madrid, where she obtained a Ph.D in Molecular Biology in 2011. Her PhD work focused on the role of microtubule dynamics in cell migration. In 2013, in a movement towards translational research, she joined the laboratory of Dr. Moasser at UCSF as a postdoctoral fellow. During her postdoc, she studied the mechanisms driving cancer progression and resistance to therapies of HER2- amplified cancers. She found a novel mechanism to target the currently undruggable HER3 and investigated the potential of HER2 to overcome HER3 requirement in HER2-amplified breast cancers. She was awarded with an EMBO fellowship and a Ramon Areces postdoctoral grant. She will start her own lab in 2019 at the Erasmus Medical Center in The Netherlands aiming to provide deeper insights into the resistance mechanisms and the metastatic process of HER2- amplified cancers that will hopefully help to define more effective strategies for this disease.

Primary Sidebar

Help us keep bringing the world’s best biology to you!

Like our Website?

You'll love our newsletter...

  • Sign up for:
    • Exclusive iBiology content
    • 10 Must See Biology Videos
    • Talks by 20+ Nobel Winners
    • Our young Scientist Survival Toolkit
    • Talks by trailblazing Women in Biology
    • Updates on exciting iBiology projects in development
    Tyler Allen
  • This field is for validation purposes and should be left unchanged.

Privacy Policy

Footer

Funders

NSF Logo
Lasker Logo
NIGMS Logo

Partners

Start Here

  • Talks for Everyone
  • Talks for Students
  • Talks for Research
  • Talks for Educators

Explore

  • Explore
  • All Playlists
  • All Speakers
  • All Talks

Talks By Topic

  • Biochemistry
  • Bioengineering
  • Biophysics
  • Cell Biology
  • Development and Stem Cells
  • Ecology
  • Genetics and Gene Regulation
  • Human Disease
  • Immunology
  • Microbiology
  • Neuroscience
  • Plant Biology
  • Techniques

Talks by Series

  • Bench to Bedside
  • Famous Discoveries
  • Great Questions
  • Share Your Research Series

Career

  • Professional Development
  • Career Exploration
  • NRMN Resources
  • Biomedical Workforce

Courses

  • Microscopy Series
  • Short Microscopy Series
  • Open edX Courses
  • Cell Biology Flipped Course
  • Engineering Life Flipped Course
  • Evolution Flipped Course

Educator

  • Educator Registration
  • Educator Resources
  • Log In

About Us

  • About Us
  • iBiology Team
  • Wonder Collaborative
  • Contact Us
  • Make a Donation
  • Mission
  • Privacy Policy

This material is based upon work supported by the National Science Foundation and the National Institute of General Medical Sciences under Grant No. MCB-1052331. Any opinion, finding, conclusion, or recommendation expressed in these videos are solely those of the speaker and do not necessarily represent the views of iBiology, the National Science Foundation, the National Institutes of Health, or other iBiology funders.

© 2021 - 2006 iBiology · All content under CC BY-NC-ND 3.0 license · Privacy Policy · Terms of Use · Usage Policy
 

Power by iBiology

   

This website uses cookies to remember you and improve your experience. To find out more see our Privacy Policy.Accept